Australia Therapeutic Device Market Overview, 2028

The therapeutic device market in Australia is at the forefront of technical innovation. The country's substantial R&D programmes, together with collaborations between universities, industry, and research institutes, generate an innovative culture. This environment fosters the development of cutting-edge therapeutic devices in a variety of areas, including cardiovascular devices, diagnostic imaging, orthopaedic solutions, and emerging disciplines such as telemedicine and wearable health technology. The Therapeutic Goods Administration (TGA) enforces stringent regulatory criteria to ensure the safety, efficacy, and quality of therapeutic devices before they are placed on the market. The TGA's comprehensive evaluation procedure boosts customer confidence and makes market access easier for products that meet stringent standards. This dedication to high standards generates an environment that encourages innovation while putting patient safety first. Australia is progressively embracing digital health solutions, resulting in an increase in the use of telemedicine, remote monitoring, and wearable health devices. Therapeutic gadgets that incorporate these digital solutions are increasing in popularity, providing prospects for improved patient care, remote consultations, and illness management, particularly in remote or underserved areas. The thriving start-up ecosystem in Australia encourages entrepreneurship in healthcare technologies. Government subsidies, accelerators, and incubators help start-ups specialising in novel medicinal devices, adding to the market's dynamism and creating an innovation culture. There is a rising emphasis on empowering patients through therapeutic gadgets. Patient-centric design and user-friendly interfaces are becoming increasingly important, allowing patients to actively participate in their healthcare management and fostering improved treatment adherence and outcomes. Australia is making advancements in personalised medicine, driving the development of treatment devices suited to an individual's genetic composition, lifestyle, and specific health needs. Advances in genomics and molecular diagnostics are assisting in the development of personalised medicinal solutions. According to the research report "Australia Therapeutic Device Market Overview, 2028," published by Bonafide Research, the Australia Therapeutic Device market is projected to add more than USD 700 Million from 2023 to 2028. The Australian government spends extensively on medical technology research and development, and there is close collaboration between universities, research institutes, and business. As a result, Australia has produced a variety of ground-breaking medicinal gadgets. The International Medical Device Regulators Forum (IMDRF) includes Australia. The IMDRF is an international conference of government bodies in charge of medical device regulation. The IMDRF is trying to standardise medical device laws worldwide. Australia is on the cutting edge of biomedical engineering, with substantial advances in improved prosthetics, implants, and biocompatible materials. Researchers have pioneered the use of 3D printing to customise implants and prosthetics, providing patients with unique options. Artificial intelligence (AI) and data analytics have been used by Australian researchers and businesses to improve diagnosis, treatment planning, and predictive modelling. Artificial intelligence-powered algorithms aid in the analysis of complicated medical data, assisting in disease detection and personalised treatment techniques. Wearable health technology is popular in the country. Smart wearable technologies that monitor vital signs, fitness trackers, and novel sensors built into clothes provide continuous health monitoring and personalised health information. Australia is investigating the use of surgical robotics in minimally invasive operations to improve precision and surgical outcomes. Furthermore, the country is investing in assistive technologies for elderly care, rehabilitation, and mobility improvement. Internet of Things (IoT) device integration into healthcare systems is gaining traction. For chronic disease management, these technologies enable remote monitoring, medication adherence, and real-time data collection.

Based on product market is segmented into insulin delivery devices, dialysis equipments, IV equipments, wound care management, and others (ventilators, sleep apnea therapeutic device, respiratory care, hearing aids). Wound care management product type is expected to lead the Australia therapeutic devices market. Diabetes and cardiovascular disease are common chronic disorders in Australia. These conditions frequently result in complications such as diabetic foot ulcers or vascular ulcers, which necessitate the use of specialised wound care management solutions for efficient treatment. Because of the country's technological prowess, advanced wound care products incorporating cutting-edge technologies have been developed. Smart dressings, bioengineered skin substitutes, and devices that promote speedier healing and infection control are among the breakthroughs. Australia's dedication to healthcare is evident in its growing healthcare spending. This initiative promotes the use of sophisticated wound care products in healthcare facilities, ensuring patients across the country have access to high-quality wound care. Based on end user segment market is divided into hospitals and clinics, home care settings, ambulatory care centers (ACCs) and other end user. Home care settings segment is expected to grow at rapid pace in Australia therapeutic devices market. Australia's expansive geography makes remote healthcare solutions essential. Therapeutic devices integrated with telemedicine and remote monitoring functionalities enable healthcare professionals to remotely monitor patients, conduct consultations, and adjust treatments, fostering the transition to home-based care. Innovations in therapeutic devices cater to home care settings, offering user-friendly, portable, and easy-to-use solutions. Devices like portable oxygen concentrators, home monitoring equipment, and mobility aids empower individuals to manage their health conditions effectively at home. Government initiatives in Australia support home care services, including funding programs and policies promoting aged care at home. This support encourages the adoption of therapeutic devices that facilitate home-based healthcare management. Based on indication market is segmented into wound care, diabetes, respiratory diseases, cardiovascular disorders & hypertension, cancer, pregnancy, hearing disorders, movement disorders and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV). Diabetes disease is major indication of therapeutic devices in Australia and is expected to grow significantly in Australia therapeutic devices market. Considered in this report: • Geography: Australia • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Aspects covered in this report: • Australia Therapeutic Device market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product: • Insulin Delivery Devices • Dialysis Equipments • IV Equipments • Wound Care Management • Others (ventilators, sleep apnea therapeutic device, respiratory care, hearing aids) By End User: • Hospitals and Clinics • Home Care Settings • Ambulatory Care Centers (ACCs) • Other End User

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Indication: • Wound Care • Diabetes • Respiratory Diseases • Cardiovascular Disorders & Hypertension • Cancer • Pregnancy • Hearing Disorders • Movement Disorders • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Therapeutic Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.